Können die für den Transport temperaturempfindlicher Impfstoffe verwendeten Trockeneispellets eingesetzt werden?

Die weltweite Verteilung temperaturempfindlicher Arzneimittel, insbesondere mRNA-Impfstoffe und biologische Proben, erfordert strikt eine ununterbrochene Kälte-Kette, die Temperaturen zwischen -70 °C und -80 °C aufrechterhält. Standard-Gelpackungen oder mechanische Kühlung können diese extremen kryogenen Bedingungen einfach nicht erreichen. Die von unseren SL-Serie Maschinen produzierten Trockeneis-Pellets sind nicht nur geeignet; sie sind der absolute Industriestandard für diese kritische Aufgabe.

Hospitals, pharmaceutical distribution hubs, and medical research facilities often rely on external gas suppliers for their dry ice. However, in the medical field, a delayed delivery or receiving degraded, sublimated dry ice can result in millions of dollars of ruined vaccines. By installing an on-site Trockeneispelletizer like the SL-50 oder SL-100, medical logistics centers eliminate supply chain vulnerabilities. You can instantly produce fresh, pure dry ice at a stable -78.5°C exactly when the insulated shipping containers are being prepared for dispatch.

Furthermore, the physical properties of the pellets play a vital role. Using our interchangeable dies, operators can produce 10mm or 16mm pellets. These spherical, high-density (1550 kg/m³) pellets can be effortlessly poured into the EPS (Expanded Polystyrene) dry ice shipping containers, tightly filling all the microscopic voids around the fragile vaccine vials. This creates an impenetrable, long-lasting thermal barrier that protects the life-saving medical cargo for days during cross-border transit, ensuring total compliance with stringent WHO (World Health Organization) cold chain guidelines.